Marianne P. Allen

Array ( [id] => 4355903 [patent_doc_number] => 06174701 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-16 [patent_title] => 'Neuronal factor' [patent_app_type] => 1 [patent_app_number] => 8/455741 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 14167 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/174/06174701.pdf [firstpage_image] =>[orig_patent_app_number] => 455741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3648730 [patent_doc_number] => 05605816 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-25 [patent_title] => 'Recombinant DNA encoding PDGF A-chain polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/454425 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9762 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/605/05605816.pdf [firstpage_image] =>[orig_patent_app_number] => 454425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1365467 [patent_doc_number] => 06566091 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-20 [patent_title] => 'Neurotrophic factor' [patent_app_type] => B1 [patent_app_number] => 08/451390 [patent_app_country] => US [patent_app_date] => 1995-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 25303 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/566/06566091.pdf [firstpage_image] =>[orig_patent_app_number] => 08451390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4035885 [patent_doc_number] => 05856301 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-05 [patent_title] => 'Stem cell inhibiting proteins' [patent_app_type] => 1 [patent_app_number] => 8/450905 [patent_app_country] => US [patent_app_date] => 1995-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 29 [patent_no_of_words] => 51236 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/856/05856301.pdf [firstpage_image] =>[orig_patent_app_number] => 450905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3937378 [patent_doc_number] => 05976533 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Monoclonal antibodies reactive with defined regions of the T cell antigen receptor' [patent_app_type] => 1 [patent_app_number] => 8/449890 [patent_app_country] => US [patent_app_date] => 1995-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 31 [patent_no_of_words] => 28804 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/976/05976533.pdf [firstpage_image] =>[orig_patent_app_number] => 449890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3930514 [patent_doc_number] => 05980892 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Monoclonal antibodies reactive with defined regions of the T cell antigen receptor' [patent_app_type] => 1 [patent_app_number] => 8/450425 [patent_app_country] => US [patent_app_date] => 1995-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 31 [patent_no_of_words] => 28888 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/980/05980892.pdf [firstpage_image] =>[orig_patent_app_number] => 450425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4404359 [patent_doc_number] => 06171799 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-09 [patent_title] => 'Monoclonal antibodies reactive with defined regions of the T cell antigen receptor' [patent_app_type] => 1 [patent_app_number] => 8/450275 [patent_app_country] => US [patent_app_date] => 1995-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 34 [patent_no_of_words] => 28762 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/171/06171799.pdf [firstpage_image] =>[orig_patent_app_number] => 450275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5999807 [patent_doc_number] => 20020028481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-07 [patent_title] => 'EXPRESSION USING FUSED GENES PROVIDING FOR PROTEIN PRODUCT' [patent_app_type] => new [patent_app_number] => 08/449070 [patent_app_country] => US [patent_app_date] => 1995-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9844 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20020028481.pdf [firstpage_image] =>[orig_patent_app_number] => 08449070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3730947 [patent_doc_number] => 05693616 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-02 [patent_title] => 'Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis' [patent_app_type] => 1 [patent_app_number] => 8/443863 [patent_app_country] => US [patent_app_date] => 1995-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13947 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/693/05693616.pdf [firstpage_image] =>[orig_patent_app_number] => 443863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4060592 [patent_doc_number] => 05866323 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-02 [patent_title] => 'Cancer diagnosis prognosis and therapy based on mutation of receptors for transforming growth factor .beta. and homologous growth controlling factors' [patent_app_type] => 1 [patent_app_number] => 8/445520 [patent_app_country] => US [patent_app_date] => 1995-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 14433 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/866/05866323.pdf [firstpage_image] =>[orig_patent_app_number] => 445520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3856660 [patent_doc_number] => 05705484 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-06 [patent_title] => 'Biologically active polypeptide fusion dimers' [patent_app_type] => 1 [patent_app_number] => 8/445847 [patent_app_country] => US [patent_app_date] => 1995-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9948 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/705/05705484.pdf [firstpage_image] =>[orig_patent_app_number] => 445847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4364448 [patent_doc_number] => 06274331 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-14 [patent_title] => 'Method of determining a functional linker for fusing globin subunts' [patent_app_type] => 1 [patent_app_number] => 8/444915 [patent_app_country] => US [patent_app_date] => 1995-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 70 [patent_figures_cnt] => 72 [patent_no_of_words] => 62058 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 187 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/274/06274331.pdf [firstpage_image] =>[orig_patent_app_number] => 444915 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1280489 [patent_doc_number] => 06642029 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-04 [patent_title] => 'Hybrid DNA synthesis of mature insulin-like growth factors' [patent_app_type] => B1 [patent_app_number] => 08/442800 [patent_app_country] => US [patent_app_date] => 1995-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3921 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/642/06642029.pdf [firstpage_image] =>[orig_patent_app_number] => 08442800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1280489 [patent_doc_number] => 06642029 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-04 [patent_title] => 'Hybrid DNA synthesis of mature insulin-like growth factors' [patent_app_type] => B1 [patent_app_number] => 08/442800 [patent_app_country] => US [patent_app_date] => 1995-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3921 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/642/06642029.pdf [firstpage_image] =>[orig_patent_app_number] => 08442800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1280489 [patent_doc_number] => 06642029 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-04 [patent_title] => 'Hybrid DNA synthesis of mature insulin-like growth factors' [patent_app_type] => B1 [patent_app_number] => 08/442800 [patent_app_country] => US [patent_app_date] => 1995-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3921 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/642/06642029.pdf [firstpage_image] =>[orig_patent_app_number] => 08442800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1280489 [patent_doc_number] => 06642029 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-04 [patent_title] => 'Hybrid DNA synthesis of mature insulin-like growth factors' [patent_app_type] => B1 [patent_app_number] => 08/442800 [patent_app_country] => US [patent_app_date] => 1995-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3921 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/642/06642029.pdf [firstpage_image] =>[orig_patent_app_number] => 08442800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4151290 [patent_doc_number] => 06156316 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-05 [patent_title] => 'Oncogene fusion protein peptide vaccines' [patent_app_type] => 1 [patent_app_number] => 8/437175 [patent_app_country] => US [patent_app_date] => 1995-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 11880 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/156/06156316.pdf [firstpage_image] =>[orig_patent_app_number] => 437175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3978292 [patent_doc_number] => 05905142 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-18 [patent_title] => 'Protease resistant PDGF and methods of use' [patent_app_type] => 1 [patent_app_number] => 8/436140 [patent_app_country] => US [patent_app_date] => 1995-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9392 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/905/05905142.pdf [firstpage_image] =>[orig_patent_app_number] => 436140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3771066 [patent_doc_number] => 05756457 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-26 [patent_title] => 'Neural regeneration using human bone morphogenetic proteins' [patent_app_type] => 1 [patent_app_number] => 8/435120 [patent_app_country] => US [patent_app_date] => 1995-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6359 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/756/05756457.pdf [firstpage_image] =>[orig_patent_app_number] => 435120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3825650 [patent_doc_number] => 05759854 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-02 [patent_title] => 'Neurotransmitter transporter' [patent_app_type] => 1 [patent_app_number] => 8/424424 [patent_app_country] => US [patent_app_date] => 1995-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8165 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/759/05759854.pdf [firstpage_image] =>[orig_patent_app_number] => 424424 [rel_patent_id] =>[rel_patent_doc_number] =>)